ABSTRACT
right but did not abolish PGE 2 -induced sensitization of the ACh response. An inositol 1,4,5-trisphosphate (IP 3 ) receptor antagonist and Ca 2ϩ entry blocker, 2-aminoethoxydiphenyl borate, abolished the ACh-induced response. Charybdotoxin, but not iberiotoxin (IbTX), inhibited the ACh-induced ⌬I SC . Clotrimazole, but not IbTX, inhibited the ACh-induced serosal K ϩ current. Under whole-cell patch clamp, ACh-induced K ϩ and Cl Ϫ currents were coincident with increases in [Ca 2ϩ ] i in single mucous cells. PGE 2 or forskolin pretreatment did not induce current or [Ca 2ϩ ] i changes but enhanced ACh-induced currents, membrane hyperpolarization, and [Ca 2ϩ ] i changes. Intracellular dialysis with the PKA-catalytic subunit enhanced AChinduced whole-cell current as well. These findings demonstrate that PGE 2 , via EP 2 receptors and the cAMP/PKA pathway, activates Ca 2ϩ entry-independent mechanisms, possibly by increasing IP 3 -mediated Ca 2ϩ release, resulting in the sensitization of ACh-induced currents.
Submucosal gland cells (SMGC) are important in maintaining normal airway mucus secretion, with serous cells specialized in secreting fluid containing bacteriostatic and nonglycosylated proteins and mucous cells secreting mucin and possibly fluid (Verkman et al., 2003) . Mucus helps in the trapping and clearance of inhaled particles and pathogens and constitutes an important part of airway-innate defense (Knowles and Boucher, 2002) .
The activation of K ϩ and Cl Ϫ channels are crucial to SMGC secretion, permitting net ion movements followed by fluid secretion (Petersen, 1992) . Serous cells express abundant CFTR Cl Ϫ channels (Engelhardt et al., 1992) and are responsible for most of the cAMP-activated fluid secretion in the airway (Wine and Joo, 2004) . Agents such as forskolin induce serous cell secretion by increasing [cAMP] i and activating CFTR (Wine and Joo, 2004) and possibly cAMP-activated K ϩ channels (Cowley and Linsdell, 2002) . The activation of CFTR allows apical anion (Cl Ϫ /HCO 3 Ϫ ) exit, driving water transport through AQP4 and AQP5 water channels (Song and Verkman, 2001) , whereas the activation of serosal K sustains anion flux by maintaining a favorable electrochemical driving force for such flux (Welsh, 1983) . Ca 2ϩ -elevating agents, such as muscarinic agonists, activate K Ca that hyperpolarizes the membrane and drive Cl Ϫ or HCO 3 Ϫ exit through apical Cl Ϫ channels (Devor et al., 1999) . In humans, CFTR is the most important Cl Ϫ channel for airway serous fluid secretion, as demonstrated in cystic fibrosis patients whose CFTR is genetically defective, leading to reduced fluid secretion. Much less is known about the ionic currents of mucous cells, a cell whose major function is to release mucin. In isolated cystic fibrosis SMGC, forskolin-induced mucus secretion was totally lost, whereas carbachol-induced secretion was partially retained, raising the possibilities that mucous cells secrete fluid via CFTR-independent mechanisms, possibly via Ca 2ϩ -activated Cl Ϫ channels (CaCC) (Wine and Joo, 2004) . Mucous cells express little CFTR (Engelhardt et al., 1992) but do have CaCC that are activated by muscarinic receptors (Griffin et al., 1996) . Mucous and serous cells are differentiated by their whole-cell current response to ACh; mucous cells produce dominant K ϩ current, whereas in serous cells, Cl Ϫ current dominates (Iwase et al., 2002) . Mucus secretion from SMGC is controlled by secretagogues and neurotransmitters, such as ACh, ATP, vasoactive intestinal peptide (VIP), and prostanoids (Ballard and Inglis, 2004) . ACh, a Ca 2ϩ -elevating agonist, is the most important neurotransmitter released by the respiratory parasympathetic nervous system (Coulson and Fryer, 2003) , whereas ATP is released locally by epithelial cells (Donaldson et al., 2000) . PGE 2 is a known cAMP-elevating agonist released by alveolar macrophages . VIP is another important cAMP-elevating agonist found in the airway, coexisting in cholinergic nerve terminals (Fischer et al., 1996) . Ca 2ϩ and cAMP are the most important second messengers responsible for the secretion of mucin and electrolyte in SMGC. Intracellular elevation of either Ca 2ϩ or cAMP can induce mucus secretion by submucosal glands (Wine and Joo, 2004) . Furthermore, these agents interact in controlling mucus secretion. For example, VIP or forskolin suppresses mucus secretion controlled by cholinergic nerve endings by activating large conductance calcium-activated K ϩ channels (BK), located in parasympathetic nerve endings, inhibiting ACh release (Liu et al., 1999) . At the cellular level, Shimura et al. (1994) showed that isoproterenol, a cAMP-elevating agonist, enhances ATP-induced whole-cell current and [Ca 2ϩ ] i changes (possibly via Ca 2ϩ entry) and increases ATP-induced mucus glycoprotein secretion in SMGC. The interactions of Ca 2ϩ -and cAMP-mediated pathways during SMGC secretion deserve further investigation because it is very possible that such interactions play important roles in regulating airway fluid and mucin secretion in pulmonary diseases, such as asthma, bronchitis, and chronic obstructive pulmonary disease (Rogers, 2002) .
In this study, we focused on such interactions in controlling ionic current and changes in [Ca 2ϩ ] i in mucous cells. So far, little is known about the ion and fluid secretion in mucous cells and their coordinated control by multiple secretagogues and hormones. In our previous study, PGE 2 , released by activated alveolar macrophage, enhanced ACh-induced ⌬I SC by increasing the apparent sensitivities of the AChinduced response (up to 3-fold decrease in EC 50 for the ACh response) in monolayers of primary cultured SMGC that were predominantly mucous cells . Prostanoids such as PGE 2 are released during airway inflammation and may be involved in mucus hypersecretion. Therefore, the mechanisms of PGE 2 -mediated sensitization of ACh-induced ionic current in mucous cells were examined by measuring I SC , whole-cell K ϩ and Cl Ϫ currents, membrane potential changes, and [Ca 2ϩ ] i using Ussing chamber studies and whole-cell patch clamp with concurrent measurement of [Ca 2ϩ ] i .
Materials and Methods
Isolation and Culture of SMGC. Isolation of SMGC was performed according to methods from this laboratory (Yang et al., 1991) . Male swine from local vendors (25-30 kg) were sacrificed by exsanguination after being anesthetized with 5% isoflurane (Rhodia Organique Fine Ltd., Bristol, UK). Fresh tracheas were also obtained from a local abattoir (Wilson Meat Packing, Crystal Springs, MS). Each trachea was quickly removed and transported to the laboratory in ice-cold physiological saline containing 100 U/ml penicillin, 100 g/ml streptomycin and 50 g/ml kanamycin. The epithelium was stripped off as a single layer, minced, and digested with 1 mg/ml collagenase IV (Worthington CLS-4; Worthington Biochemical Corporation, Freehold, NJ), 0.5 mg/ml dithiothreitol, and 0.5 mg/ml DNase I (DN-25l; Sigma-Aldrich, St. Louis, MO) in Dulbecco's modified Eagle's culture media at 37°C for 4 to 6 h. Isolated cells were centrifuged through a discontinuous 10, 20, 30, 40, and 60% Percoll gradient at 500g for 10 min. SMGC concentrated at the interface between the 40 and 60% layers and were removed, washed, and resuspended in PC-1 medium containing 2 mM GlutaMAX (Invitrogen, Carlsbad, CA), serum substitutes (Cambrex Bio Science Walkersville, Inc., Walkersville, MD), and antibiotics. Cells were then plated on inserts (described below) for Ussing chamber studies. Some cells were plated on glass coverslips (VWR, West Chester, PA) coated with poly-L-lysine (P-4707; Sigma-Aldrich) and collagen type IV for patch-clamp studies. SMGC were attached to the coverslip within 2 h after plating. Cells were then used immediately for patch-clamp studies.
SMGC Culture at an Air-Liquid Interface Using Culture Inserts. Millicell-CM inserts (0.45 m pore size, 0.6 cm 2 area; Millipore, Bedford, MA) were each coated with 75 l of human placental collagen (0.5 mg/ml in 0.2% acetic acid and further diluted in 70% ethanol 1:3 v/v). The collagen coating was air-dried and then crosslinked by exposure to ammonium hydroxide vapors (3%) for 10 min followed by immersion in glutaraldehyde (2.5%) for 10 min. The coated inserts were washed once in distilled water, once in 70% ethanol, three times in distilled water, and finally incubated in culture media for 30 min before plating the cells (Takacs-Jarrett et al., 1998) . Approximately 10 6 cells were plated on each insert. One day after plating, the medium inside the inserts was removed, allowing the cells to grow at an air interface to maintain phenotype (Finkbeiner et al., 1994) . Medium under the insert was changed every 2 days, and any solution inside the inserts was removed. Cells were maintained in culture for 3 to 5 days before measurement of I SC .
I SC Measurement. Confluent mucous cell monolayers grown on Millicell-CM inserts were mounted in Ussing chambers (Corning Life Sciences, Acton, MA), each modified to accept the Millicell inserts. The chambers were maintained at 37°C and continuously bubbled with gas mixture (95% O 2 ϩ 5% CO 2 ). The bubbling also served to drive the circulation that quickly mixed drugs after the addition to the serosal or apical chamber, each having a maximal volume of 10 ml. The transepithelial I SC was measured using VCC600 voltageclamp amplifiers (Physiologic Instruments, San Diego, CA) connected to the chambers via salt bridges and silver/silver chloride pellet electrodes. The current across the confluent monolayers of SMGC was measured under voltage clamp, with the potential across the membrane set at 0 mV. Compounds (ACh, forskolin, 2-APB, and
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Liu and Farley at ASPET Journals on April 13, 2017 jpet.aspetjournals.org so on) were added to the serosal or apical solution from concentrated stock solutions (at least 1000 times concentrated). At the beginning of each experiment, amiloride (10 M) was applied apically to block the epithelial Na ϩ channel activity, which can be found in the gland duct epithelia of submucosal gland acini and in the primary cultured SMGC (Yamaya et al., 1991) . For cumulative ACh treatments, ACh was added serosally in the order of 0.003, 0.01, 0.03, 0.1, 0.3, 1, and 3 M final concentrations. Only a small amiloride-sensitive current was recorded as shown in a previous study , suggesting a minimal contamination of surface or duct epithelial cells. The increases in I SC in response to ACh, PGE 2 , or forskolin were measured as the peak currents obtained after the addition of agonist at each concentration subtracted from the baseline current measured before the addition of initial concentration of the agonist. The currents were normalized to the area of the insert (0.6 cm 2 ). Ussing chamber solution contained 128 mM NaCl, 4.6 mM KCl, 2.5 mM CaCl 2 , 1.2 mM MgSO 4 , 1.2 mM KH 2 PO 4 , 11.2 mM glucose, pH adjusted to 7.4 before adding 25 mM NaHCO 3 (Moon et al., 1997) . In Ca 2ϩ -free solution, CaCl 2 was replaced with 2.5 mM MgCl 2 and 0.5 mM EGTA.
Serosal Membrane K ؉ Current Measurement. Methanesulfonic acid (MeSO 4 )-based Ussing chamber solutions were used to study the serosal K ϩ current. The serosal solution contained 145 mM NaMeSO 4 and 5 mM KMeSO 4 ; the apical solution contained 150 mM KMeSO 4 ; and the remaining components of both serosal and apical solution were 2.5 mM CaCl 2 , 1.2 mM MgSO 4 , 1.2 mM NaH 2 PO 4 , 11.2 mM glucose, and 10 mM HEPES. Osmolarity was adjusted to 320 mOsm, with mannitol and the pH adjusted to 7.4 at 37°C with NaOH. These solutions were bubbled with 100% O 2 . Nystatin (100 M) was used to permeabilize the apical membrane to monovalent ions, such as Cl Ϫ , Na ϩ , and K ϩ . When these solutions were used, a 30:1 apical to serosal K ϩ gradient was established after Nystatin permeabilization.
Patch-Clamp Experiments. Whole-cell current and membrane potential recording were performed according to a previous report (Hamill et al., 1981) . Patch pipettes were pulled from borosilicate glass (FMG 15; Dagan Corp., Minneapolis, MN) using a DMZ Universal Electrode Puller (Zeitz, Augsburg, Germany) and then firepolished immediately before filling with pipette solution. The pipettes had resistances of approximately 4 M⍀ when filled with internal solution. Gigaohm seals were readily formed between the mucous cell membrane and pipette by applying gentle suction to the pipette. The seal resistances obtained were greater than 2 G⍀. The whole-cell configuration was formed by rupture of the cell membrane by further suction. For whole-cell current recording, the membrane potential was held at Ϫ40 mV, and the potential was ramped over 200 ms from Ϫ100 to ϩ40 mV every 2 s. This permitted measurement of both K ϩ current and Cl Ϫ current at 0 and Ϫ80 mV, the equilibrium potentials for Cl Ϫ and K ϩ , when external and internal solutions as described below were used (as demonstrated in Fig. 6 ). The K ϩ and Cl Ϫ current amplitudes at these potentials were measured by subtracting baseline currents from the currents obtained after agonist stimulation. Whole-cell membrane potentials were recorded using the current-clamp mode. Current and voltage data were acquired at 2 kHz and filtered at 1 KHz using an Axopatch 200B amplifier (Molecular Devices, Sunnyvale, CA). The data acquisition software used was Axon pClamp version 9. Patch-clamp data were analyzed using Clampfit 9.0 (Molecular Devices) and Origin 7.0 (Origin Lab, Northampton, MA). External solution for whole-cell measurements consisted of 140 mM NaCl, 6 mM KCl, 1 mM MgCl 2 , 1 mM CaCl 2 , 10 mM glucose, and 10 mM HEPES, with pH adjusted to 7.4 with NaOH. The internal solution consisted of 140 mM KCl, 8 mM NaCl, 1 mM MgCl 2 , 0.05 mM EGTA, 5 mM MgATP, 1 mM Na 3 GTP, and 10 mM HEPES, with pH adjusted to 7.2 with NaOH. External solutions were superfused over cells by gravity feed. All recordings were performed at room temperature.
Concurrent Single-Cell Ca 2؉ Fluorescence Recording. Fluo-4 pentapotassium salt, a membrane-impermeable Ca 2ϩ fluorescent dye (Invitrogen), was used to measure Ca 2ϩ fluorescence signals. The dye was prepared as a 10 mM stock solution in water and freshly diluted in internal solution to 10 M. During whole-cell formation, the dye was dialyzed via the patch pipette directly into the cytosol of mucous cells. A 5-min period after whole-cell formation was sufficient for the dialysis of the cytosol. Fluo-4 fluorescence was measured using a 60ϫ Nikon oil immersion objective lens (numerical aperture 1.4). The dye was excited by a Xenon 75W lamp (Chiu Technical Corporation, Kings Park, NY), and emission was recorded at 511 nm. Fluorescent brightness was recorded by a CCD camera coupled to an intensifier (CCD72; MTI, Fremont, CA) every 1 or 2 s via a DT3155 digitizer (Data Translation, Marlboro, MA) and analyzed using ImagingWorkbench 5 software (INDEC BioSystems, Santa Clara, CA). Region brightness data from images were exported to Origin 7.0 (OriginLab Corp., Northampton, MA) for analysis. The ratio of (fluorescence signal Ϫ basal fluorescence signal)/basal fluorescence signal (F Ϫ F 0 )/F 0 , was used to represent relative changes in [Ca 2ϩ ] i .
Reagents. AH6809 (6-isopropoxy-9-oxoxanthene-2-carboxylic acid) and SC19220 [8-chloro-dibenzo[b,f] [1,4]oxazepine-10(11H)-carboxylic acid, 2-acetylhydrazide] were purchased from Cayman Chemical (Ann Arbor, MI). PKI and Rp-cAMPs were purchased from BIOMOL International, L. P. (Plymouth Meeting, PA); and SKF96365 was purchased from Fisher Scientific Co. (Pittsburgh, PA). Other chemicals, such as 2-APB, ChTX, clotrimazole, forskolin, IbTX, and PGE 2 , were purchased from Sigma-Aldrich, unless specifically noted in the text.
Statistics. Data are presented as mean Ϯ S.E.M., and n is the number of inserts or animals used as described in the text. EC 50 values for the ACh-induced I SC responses are presented with 95% confidence interval (95% CI). Because there were considerable differences among the ACh-induced maximal ⌬I SC in primary cultures from different animals, for I SC measurements, matched inserts with identical culture and experimental conditions from the same animal were subject to different treatments. Cells from at least three animals per experimental protocol were performed. The statistical method used to differentiate differences between treatments was one-way repeated measures analysis of variance (or on ranks whenever appropriate) plus post hoc tests. ACh-induced ⌬I SC was normalized to the maximal ⌬I SC from each insert before calculating average concentration responses (average maximal ⌬I SC from each treatment is also provided). For whole-cell current, membrane potential, and Ca 2ϩ measurements, the same treatment data from a single animal were averaged before calculating mean Ϯ S.E.M. One-way ANOVA (or on ranks) was used whenever appropriate to test statistical difference between multiple treatments. ‫,ء‬ p Ͻ 0.05 indicates significance of difference.
Results

Effect of PGE 2 or Forskolin Pretreatment on the
ACh-Induced I SC . The resting transepithelial potentials, currents, and resistances for confluent SMGC monolayers were reported in a previous study ; in the same study we also reported that PGE 2 pretreatments (10 nM to 1 M) sensitized ACh-induced ⌬I SC . Similar Ussing chamber studies on ACh-induced ⌬I SC across mucous gland cell monolayers grown on CM inserts were performed. ACh alone induced average maximal ⌬I SC of 36.2 Ϯ 7.3 A/cm 2 , with an EC 50 of 151 nM (95% CI 113-191 nM; n ϭ 4) in Control. PGE 2 or forskolin pretreatment induced persistent increases in I SC (14.3 Ϯ 4.9 and 12.8 Ϯ 3.4 A/cm 2 , respectively, n ϭ 4 each). EC 50 values for the ACh-induced ⌬I SC after PGE 2 or forskolin pretreatment were 47 nM (95% CI 38 -58 nM; n ϭ 4) and 43 nM (95% CI 34 -52 nM; n ϭ 4), respectively, both significantly smaller than EC 50 in Control (Fig. 1, A and B) . EC 50 values for the ACh-induced ⌬I SC in Control (no PGE 2 pretreatment), PGE 2 pretreatment group (0.1 M), and AH6809 ϩ PGE 2 group were 147 nM (95% CI 85-223 nM), 59 nM (95% CI 27-91 nM; p Ͻ 0.05 versus Control), and 87 nM (95% CI 47-128 nM; p Ͻ 0.05 versus Control or PGE 2 group), respectively (n ϭ 4 each). Pretreating mucous cell monolayers with AH6809 before PGE 2 and ACh applications shifted the ACh concentration-response relationships to the right compared with those in PGE 2 group (Fig. 1B) . The EP 1 receptor antagonist SC19220 did not reverse the PGE 2 -induced sensitization of mucous cells in response to ACh to increase I SC (EC 50 ϭ 35 nM, 95% CI 31-38 nM; n ϭ 4; p Ͼ 0.05 versus PGE 2 group).
The PKA inhibitor, myristoylated PKI (14-22) amide (2 M, Fig. 1 , C and D), reduced the PGE 2 -induced sensitization of mucous cells in response to ACh. EC 50 values for the ACh-induced I SC responses in Control group, PGE 2 -pretreatment group, and PKI ϩ PGE 2 group were 476 nM (95% CI 83-1033 nM), 87 nM (95% CI 30 -154 nM; p Ͻ 0.05 versus Control), and 179 nM (95% CI 62-325 nM; p Ͻ 0.05 versus Control or PGE 2 -pretreatment group), respectively (n ϭ 4 each). PKI applied before PGE 2 and ACh applications significantly shifted the ACh concentration-response relationships to the right relative to those of PGE 2 group (Fig. 1D) . Another PKA inhibitor, Rp-cAMP (100 M, serosal), was also effective in reducing the sensitization by PGE 2 (0.1 M) to AChinduced mucous cell ⌬I SC . The average EC 50 for the ACh response was 61 nM (95% CI 53-77 nM) in the Rp-cAMPs ϩ PGE 2 group, significantly greater than that of the PGE 2 -pretreatment group (EC 50 ϭ 41 nM, 95% CI 29 -56 nM) running in parallel (P Ͻ 0.05, paired t test; n ϭ 5 each). Tyrosine kinase inhibition using genistein (50 M) or the receptor tyrosine kinase inhibitor tyrphostin AG1478 (1 and 10 M) did not alter the action of PGE 2 (data not shown).
PGE 2 -Sensitized ACh-Induced ⌬I SC in the Absence of Extracellular Ca 2؉ . We tested whether extracellular Ca 2ϩ is required for the effect of PGE 2 on the ACh-induced ⌬I SC .
As shown in Fig. 2A , in 0 mM [Ca 2ϩ ] o cumulative application of ACh (serosal) induced increases in I SC similar to those found in Fig. 1 but with a more rapidly declining tail. In Control, without PGE 2 pretreatment, the average EC 50 for the ACh-induced ⌬I SC (Fig. 2 , A, trace 1, and B, gray squares) was 217 nM (95% CI 151-289 nM; n ϭ 4). Compared with control, PGE 2 pretreatments (0.1 and 1 M in Fig. 2 Fig. 3A , traces 3, 4, and 5, respectively) applied before PGE 2 and ACh applications significantly decreased ACh-induced peak ⌬I SC response compared with that in PGE 2 group (p Ͻ 0.05), with average ⌬I SC responses being 45.4 Ϯ 5.4, 35.4 Ϯ 6.1, and 23.9 Ϯ 2.6 A/cm 2 , respectively. Also shown in Fig. 3B , middle and bottom graphs, PGE 2 pretreatment significantly increased the rate of the decline of ACh-induced I SC responses at T 1/2 , but not at T 3/4 , compared with those in Control. SKF96365 treatments (25 and 50 M) significantly shortened the T 1/2 for the decline of ACh-induced ⌬I SC compared with Control (p Ͻ 0.05) and significantly shortened the T 3/4 for the decline of ACh-induced ⌬I SC compared with Control, PGE 2 group, or 5 M SKF96365 ϩ PGE 2 group (p Ͻ 0.05).
SKF96365 (25 and 50 M) significantly inhibited 1 M PGE 2 -induced ⌬I SC (Fig. 3A) . Average plateau ⌬I SC responses were 17.8 Ϯ 5.9 A/cm 2 for PGE 2 alone and 9.8 Ϯ 2.5 and 8.9 Ϯ 3.6 A/cm 2 for PGE 2 in the presence of 25 or 50 M SKF96365 (p Ͻ 0.05 versus PGE 2 alone; n ϭ 3 each).
The effect of SKF96365 on concentration-response relationships for ACh-induced ⌬I SC was also examined. SKF96365 (25 and 50 M; Fig. 3C , traces 2 and 3, respectively), applied before PGE 2 pretreatment (1 M), decreased the ACh-induced ⌬I SC at lower ACh concentrations (0.01-0.3 M), causing rapid decline of I SC after the peak response, relative to the ACh-induced increase after pre-exposure to PGE 2 (PGE 2 group, trace 1). EC 50 values for the ACh-induced responses after 1 M PGE 2 pretreatment only (Fig.  3D , top graph, black squares), PGE 2 ϩ 25 M SKF96365 (Fig. 3D , black upward triangles), and PGE 2 ϩ 50 M SKF96365 (Fig. 3D, black 2 ) and increased EC 50 for the ACh response (482 nM, 95% CI 324 -668 nM) (P Ͻ 0.05 versus Control, n ϭ 3). As shown in Fig. 3D , SKF96365 treatments (25 and 50 M) shifted the ACh concentration-response relationships to the right, both in the presence (top graph, black symbols) or absence of PGE 2 (bottom graph, open symbols), whereas PGE 2 induced left shifts of ACh concentration-response rela- Fig. 3 . Effects of SKF96365 and PGE 2 on the ACh-induced ⌬I SC . A, a single submaximal concentration of ACh (0.1 M, serosal, trace 1, Control) induced a transient increase in I SC . PGE 2 (1 M, serosal, trace 2), applied 5 min before ACh application, induced a relatively persistent increase in I SC , after which ACh induced a larger increase in I SC that declined with a similar rate to Control. SKF96365 (5, 25, and 50 M, serosal: traces 3, 4, and 5, respectively) applied 5 to 10 min before PGE 2 and ACh applications, caused the ACh-induced I SC to decline more rapidly. B, summary of analysis of data, as in A, are shown. Top panel shows the effect of PGE 2 and SKF96365 on the ACh-induced peak ⌬I SC , and the middle and bottom panels show the duration for the peak I SC to decline to 50% maximal ⌬I SC (T 1/2 , in seconds) and to 25% maximal ⌬I SC (T 3/4 , in seconds), respectively. Note that SKF96365 significantly decreased the peak current induced by ACh ‫ء(‬ p Ͻ 0.05 compared with PGE 2 group, bar no.2) and at 25 and 50 M enhanced the rate of I SC decline ‫,ء(‬ p Ͻ 0.05 compared with control). Total of three inserts from three animals for each experiment. C, trace 1, ACh was cumulatively applied in the presence of PGE 2 (1 M) to induce increases in I SC similar to those shown in Fig. 1 . SKF96365 (trace 2, 25 M, and trace 3, 50 M, serosal) was applied before PGE 2 and ACh treatments. D, the concentration-response relationships for the ACh-induced ⌬I SC are shown (normalized to maximal ⌬I SC from each insert) in the presence of SKF96365 (0, 5, 25, and 50 M) with PGE 2 pretreatment (1 M, filled black labels, top graph) or without PGE 2 pretreatment (empty labels, bottom graph); n is the number of inserts used, three to four animals were used for each group. Note that SKF96365 caused right shifts in concentration-response relationships of the ACh-induced response in both graphs. PGE 2 treatment in top graph caused similar magnitude of left shifts in the concentration-response relationships relative to groups treated with identical concentrations of SKF96365 in the bottom graph.
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at ASPET Journals on April 13, 2017 jpet.aspetjournals.org tionships in the presence of equal concentrations of SKF96365 to a similar extent (Fig. 3D) , suggesting that PGE 2 induced the sensitization of ACh response by a Ca 2ϩ entry-independent mechanism. However, as shown for the effects of Ca 2ϩ removal, Ca 2ϩ entry is important in the response to ACh.
Effect of 2-APB on the ACh-Induced ⌬I SC and PGE 2 -Induced Sensitization of ACh Response. 2-APB, a known IP 3 -receptor antagonist and Ca 2ϩ entry blocker (Bootman et al., 2002) , was used to examine the role of Ca 2ϩ -release (IP 3 -induced) and Ca 2ϩ entry in the ACh-induced ⌬I SC and PGE 2 -induced sensitization of the ACh response. Inserts used to test the effect of 2-APB on the ACh response (0.1 M) and time course were from the same animals used in SKF96365 experiments (Control and PGE 2 -treatment groups are the same as those in Fig. 3, A and B) . Serosal application of 2-APB (5, 25, or 100 M in Fig. 4A, traces 3, 4 , and 5, respectively) before PGE 2 and ACh application significantly decreased ACh-induced peak ⌬I SC compared with PGE 2 group (P Ͻ 0.05). The average peak ⌬I SC responses were 48.8 Ϯ 11.7, 26.9 Ϯ 4.3, and 1.4 Ϯ 0.4 A/cm 2 , respectively (5, 25, or 100 M 2-APB; Fig. 4B , top panel). There were significant differences in ACh-induced peak ⌬I SC between 5 and 25 M groups (P Ͻ 0.05) and between 25 and 100 M groups (P Ͻ 0.01). Furthermore, each 2-APB treatment significantly accelerated the decline of ACh-induced I SC compared with PGE 2 group (Fig. 4B , middle, T 1/2 data; and bottom, T 3/4 data). As shown in Fig. 4A , PGE 2 -induced plateau ⌬I SC responses were significantly reduced by all 2-APB pretreatments at 5, 25, and 100 M (P Ͻ 0.05). PGE 2 -induced average plateau ⌬I SC responses were 21.1 Ϯ 3.2 (PGE 2 alone), 14.5 Ϯ 2.3, 13.2 Ϯ 4.6, and 3.1 Ϯ 0.6 A/cm 2 (5, 25, and 100 M 2-APB, respectively).
The effect of 2-APB on concentration-response relationships for the ACh-induced ⌬I SC was also tested. Serosal application of 100 M 2-APB before PGE 2 and ACh treatments greatly reduced ACh-induced peak ⌬I SC (4.0 Ϯ 1.1 A/cm 2 ; Fig. 4C , trace 2, n ϭ 5) compared with Control (50.7 Ϯ 6.4 A/cm 2 ; Fig. 4C , trace 1, n ϭ 5). Not shown in the figure, serosal application of 25 M 2-APB before PGE 2 treatment (1 M) significantly decreased ACh-induced peak ⌬I SC and increased EC 50 for the ACh response. Peak ⌬I SC responses were 26.9 Ϯ 5.6 and 13.1 Ϯ 3.4 A/cm 2 (n ϭ 7, p Ͻ 0.05), and the average EC 50 values were 99 (95% CI 58 -133 nM) and 155 nM (95% CI 78 -214 nM) for Control and 2-APB group (25 M), respectively. At 5 M, 2-APB did not change the peak ⌬I SC or EC 50 for the ACh response (data not shown).
Intermediate Conductance Ca 2؉ -Activated K ؉ Channel (IK), but Not BK, Were Involved in the ACh-Induced I SC . Previously, we showed that ChTX, a BK and IK channel blocker, inhibited ACh-induced I SC . Here we used IbTX, a specific blocker for BK in addition to ChTX, to determine the type of K ϩ channels involved in the ACh -induced I SC . ChTX, but not IbTX, significantly inhibited ACh-induced ⌬I SC in the presence of 1 M PGE 2 (Fig. 5,  A and B) . ACh-induced maximal ⌬I SC responses were 52.9 Ϯ 8.2, 49.3 Ϯ 7.3, and 11.5 Ϯ 0.8 A/cm 2 in Control (PGE 2 pretreatment only), IbTX group (PGE 2 ϩ 100 nM IbTX), and Fig. 3A , 2-APB (5, 25, and 100 M in traces 3, 4, and 5, respectively) was added serosally before PGE 2 and ACh applications. Both PGE 2 and ACh-induced peak ⌬I SC were decreased, and the decline of ACh-induced I SC was more rapid than control in the presence of 2-APB. B, the effects of 2-APB and PGE 2 on the AChinduced peak ⌬I SC (top) and also the time to decay to 50 (middle) and 25% (lower) of peak are shown in bar graphs (three inserts from three animals for each treatment; ‫,ء‬ p Ͻ 0.05 compared with the respective values in bar no 2: PGE 2 -only). C, 2-APB (100 M, trace 2) was added serosally 5 to 10 min before PGE 2 (1 M) and cumulative ACh application. ACh-induced I SC in the presence of PGE 2 were greatly reduced by 100 M 2-APB (typical of three inserts from three animals). . Here we used clotrimazole, an IK or KCNN4 blocker (Devor et al., 1999) , to examine the types of Ca 2ϩ -activated K ϩ channels (K Ca ) involved in ACh-induced ⌬I SC and cAMP-mediated sensitization of the ACh response. As shown in Fig. 5C , trace 1 (Control), after nystatin permeabilization of the apical membrane, ACh induced increases in serosal K ϩ current, with an average maximal current of 187.3 Ϯ 40.5 A/cm 2 and EC 50 of 161 nM (95% CI 121-206 nM; n ϭ 3). Forskolin pretreatment (10 M, serosal; Fig. 5C , trace 2) sensitized the ACh-induced K ϩ current (EC 50 ϭ 67 nM, 95% CI 56 -78 nM; n ϭ 3, p Ͻ 0.05 versus Control) but did not change the ACh-induced maximal K ϩ current (148.2 Ϯ 37.3 A/cm 2 ; p Ͼ 0.05 versus Control). In the presence of 40 nM IbTX and forskolin (Fig. 5C, trace 3) , the average ACh-induced maximal K ϩ current was 181.0 Ϯ 48.5 A/cm 2 , and EC 50 for the ACh response was 73 nM (95% CI 48 -102 nM; n ϭ 3), and each was not significantly different from that in forskolin group (P Ͼ 0.05).
In separate experiments, after forskolin pretreatment (10 M, serosal; Fig. 5D , trace 1), ACh induced an average maximal K ϩ current of 167.0 Ϯ 27.8 A/cm 2 , with an EC 50 of 61 nM (95% CI 40 -81 nM; n ϭ 5), similar to those found in Fig.  5A . Clotrimazole (50 M, serosal) was applied before forskolin pretreatment (Fig. 5D, trace 2) ; afterward, the ACh-induced maximal K ϩ current was 58.7 Ϯ 15.5 A/cm 2 , and EC 50 for the ACh response was 174 nM (95% CI 112-241 nM; n ϭ 5). Clotrimazole significantly decreased ACh-induced maximal K ϩ current and increased EC 50 for ACh response (P Ͻ 0.05 versus forskolin group). Figure 5E summarizes the effect of forskolin, IbTX, and clotrimazole on the concentration-response relationships for ACh-induced K ϩ current. 5 . IK, but not BK, were involved in the ACh-induced I SC . A, ChTX (100 nM, trace 2) or IbTX (100 nM, trace 3) was added serosally after PGE 2 (1 M) but before ACh application. In Control (trace 1), no K ϩ blockers were applied. Note that the baselines for the traces in A (also in C) were offset for clarity. B, summary of concentration-response relationships for the ACh-induced I SC (normalized to percentage of the ACh-induced maximal I SC in Control, n ϭ 3 each) are shown. ChTX, but not IbTX, decreases the magnitude of ACh-induced I SC compared with that in Control. C, the apical membranes of monolayers were permeabilized with 100 M nystatin (at the first arrow) to monovalent ions, and a 30:1 apical to serosal K ϩ gradient was established as described under Materials and Methods. Trace 1 shows currents induced by cumulative ACh in a control recording without forskolin treatment. In trace 2, Forskolin (10 M, serosal), added 5 to 10 min before cumulative ACh treatment, enhanced ACh-induced K ϩ current. In trace 3, IbTX (40 nM) was added serosally before forskolin and ACh additions. D, clotrimazole (50 M, serosal, trace 2) was added before the forskolin and ACh treatments. Trace 1 shows a forskolin pretreatment recording without K ϩ channel blocker treatment (similar to trace 2 in A). E, the effects of forskolin and K ϩ channel blockers on concentration-response relationships for the ACh-induced K ϩ current from experiments presented in C and D are shown (n is the number of inserts used, two-to three animals were used in each group). Forskolin treatment sensitizes the ACh-induced serosal K ϩ current.
at ASPET Journals on April 13, 2017 jpet.aspetjournals.org
Downloaded from
As shown in the Fig. 5C , forskolin (10 M) alone induced a peak average K ϩ current of 155.5 Ϯ 14.6 A/cm 2 , whereas in the presence of 40 nM IbTX, forskolin induced an average K ϩ current of 177.1 Ϯ 33.8 A/cm 2 (n ϭ 3, p Ͼ 0.05 versus forskolin alone, paired t test). As shown in Fig. 5B , forskolin (10 M) alone induced an average K ϩ current of 153.8 Ϯ 16.8 A/cm 2 (n ϭ 5), whereas in the presence of 50 M clotrimazole, forskolin-induced average K ϩ current was 76.4 Ϯ 19.6 A/cm 2 (n ϭ 5, p Ͻ 0.05 versus forskolin alone). Therefore clotrimazole but not IbTX inhibited forskolin and ACh-induced serosal K ϩ current. PGE 2 and Forskolin Enhanced ACh-Induced Mucous Cell Whole-Cell K ؉ and Cl ؊ Current and [Ca 2؉ ] i . Upon whole-cell formation, mucous cells were dialyzed with internal solution with a Cl Ϫ concentration equal to that of external solution. The average mucous cell capacitance was 6.48 Ϯ 0.15 pF, and cell capacitances among cells from different animals were not significantly different (P Ͻ 0.05, 28 cells from five animals). Whole-cell membrane resistance and access resistance were 2.8 Ϯ 0.3 G⍀ and 23 Ϯ 3 M⍀ (total of 30 cells from six animals), respectively, at a 0-mV holding potential.
Voltage-ramp protocols were used to detect changes in ACh-induced whole-cell K ϩ and Cl Ϫ channel current as described under Materials and Methods (Fig. 6, A and B) . Cells enriched by discontinuous Percoll gradient were large with abundant large nonhomogeneous granules (Fig. 6E 1 ) and previously identified using periodic acid Schiff-Alcian Blue staining methods as mucous cells (Yang et al., 1991) . As shown in Fig. 6C , top, for a mucous cell, superfusion with 10 M ACh induced a K ϩ current (triangles) and a smaller Cl Ϫ current (circles). I-V relationships for ACh-induced wholecell current are shown in Fig. 6D . The reversal potential of ACh-induced current trace is close to Ϫ80 mV, the equilibrium potential for K ϩ using these solutions. Both K ϩ and Cl Ϫ currents developed transiently to peaks that were followed by declining tails in the continuous presence of ACh. In some experiments, fluo-4 potassium salt (10 M) was included in the patch pipette to measure Ca 2ϩ concurrently (Fig. 6 , E 2 -E 4 ). Ca 2ϩ signals were measured as fluo-4 fluorescence Fig. 6 . ACh-induced SMGC whole-cell current and Ca 2ϩ fluorescence signal. A, stacked current sweeps (top) generated by the voltage-ramp protocol (bottom) and whole-cell current recording during the application of ACh are shown. The membrane potential was held at Ϫ40 mV, and the potential was ramped over 200 from Ϫ100 to ϩ40 mV every 2 s. K ϩ and Cl Ϫ currents were recorded at 0-and Ϫ80-mV membrane potentials (equilibrium potentials for Cl Ϫ and K ϩ , respectively). B, raw current traces (top) and voltage ramps (bottom) during the same experiment are shown. C, the top panel shows the development of K ϩ and Cl Ϫ currents induced by 10 M ACh (marked at arrow) extracted from current traces in A and B. The bottom panel shows the development of Ca 2ϩ signal measured concurrently using fluo-4 dye. D, I-V relationships derived from individual current traces during the voltage ramp at times marked by letters a, b, and c in C (a, before ACh treatment; b, time point at peak ACh current response; c, recovery). E 1 shows a bright-field image of patched mucous cell; E 2 through E 4 show the fluorescence images at times a, b, and c shown in C (representative of six cells from three animals). fluorescence signals were coincident with ACh-induced changes in whole-cell currents (Fig. 6C, bottom) . To examine the effect of PGE 2 or forskolin on the AChinduced [Ca 2ϩ ] i changes, we measured intracellular Ca (Fig. 7A) . ACh at 0.3 M induced little or no K ϩ or Cl Ϫ currents (Fig. 7A, bottom) , with the K ϩ and Cl Ϫ current amplitudes of 19 Ϯ 7 and Ϫ1 Ϯ 1 pA/pF, respectively (Fig. 7F, 10 cells from seven animals). ACh at 10 M induced significant K ϩ (189 Ϯ 18 pA/pF) and Cl Ϫ currents (Ϫ21 Ϯ 5 pA/pF, 10 cells from seven animals; Fig. 7F ). As shown in Fig. 7 , B and C, neither PGE 2 (1 M) nor forskolin (10 M) induced significant changes in [Ca 2ϩ ] i or K ϩ and Cl Ϫ currents. However, in the presence of PGE 2 or forskolin, ACh at 0.3 M now induced significant Ca 2ϩ signals (FϪ F 0 /F 0 ϭ 0.62 Ϯ 0.16, four cells from four animals, and 0.57 Ϯ 0.13, three cells from three animals, respectively), which were significantly greater than those induced by 0.3 M ACh alone (p Ͻ 0.01), but not different from 10 M ACh alone (P Ͼ 0.05). PGE 2 induced little or no ion channel activity (K ϩ current: 11 Ϯ 3 pA/pF; Cl Ϫ current: Ϫ1 Ϯ 1 pA/pF, seven cells from five animals; Fig. 7, B and F) , and neither did forskolin (K ϩ current: 7 Ϯ 3 pA/pF; Cl Ϫ current: 0 Ϯ 1 pA/pF, six cells from five animals; Fig. 7, C and F) . However, after PGE 2 pretreatment, 0.3 M ACh-induced K ϩ current was 156 Ϯ 29 pA/pF, and Cl Ϫ current was Ϫ19 Ϯ 7 pA/pF (Fig. 7, B and F, seven cells from five animals). After forskolin pretreatment, 0.3 M ACh induced 163 Ϯ 33 pA/pF K ϩ current and Ϫ39 Ϯ 14 pA/pF Cl Ϫ current (Fig. 7 , C and F, six cells from five animals). The amplitudes of ACh-induced K ϩ currents and Cl Ϫ currents obtained after PGE 2 or forskolin were significantly larger than those induced by 0.3 M ACh alone (P Ͻ 0.05) but were not different from those induced by 10 M ACh (P Ͼ 0.05, Fig. 7F ).
When 250 U/ml PKA catalytic subunit was included in the patch pipette, 0.3 M ACh-induced K ϩ and Cl Ϫ currents were 163 Ϯ 13 and Ϫ40 Ϯ 4 pA/pF, respectively, and 10 M ACh induced 170 Ϯ 17 and Ϫ50 Ϯ 10 pA/pF currents (Figs. 7D and 8E, five cells from three animals). The current induced by 0.3 M ACh in the presence of PKA catalytic subunits was significantly larger than that caused by 0.3 M ACh alone, but not different from that induced by 10 M ACh alone, or by 0.3 M ACh in the presence of forskolin (10 M) or PGE 2 (1 M) (Fig. 7E) .
PGE 2 and Forskolin Enhanced ACh-Induced Membrane Hyperpolarization in Mucous Cells. ACh-induced membrane hyperpolarization in mucous cells was examined using whole-cell current clamp mode (I ϭ 0). Baseline membrane potential was Ϫ12.0 Ϯ 2.4 mV (12 cells, seven animals), with transient hyperpolarizations observed (Fig. 8, A and B). ACh at 0.3 M caused a small, transient hyperpolarization (Fig. 8A ) to Ϫ31.1 Ϯ 11.2 mV (Fig. 8C , six cells from five animals). ACh at 10 M induced a persistent hyperpolarization to Ϫ67.6 Ϯ 2.8 mV (five cells from five animals; Fig. 8C ), significantly larger than that caused by ACh at 0.3 M (P Ͻ 0.01). The potential slowly recovered after ACh was washed away (Fig. 8A) . Pretreatment with 1 M PGE 2 for at least 3 min before ACh application caused a slow depolarization of the membrane to an average baseline of Ϫ1.7 Ϯ 2.5 mV (Fig. 8, B and C, seven cells from five animals). After development of the PGE 2 -induced depolarization, additional exposure to 0.3 M ACh induced a stable hyperpolarization to Ϫ65.2 Ϯ 4.6 mV (seven cells from five animals), which was significantly different from the membrane potential induced by 0.3 M ACh alone (Fig. 8C , ‫,ءء‬ p Ͻ 0.01) but not different from that of 10 M ACh (Fig. 8C, p Ͼ 0.05) .
Discussion
The present study demonstrated that PGE 2 increased the apparent sensitivities of ACh-induced ⌬I SC in mucous cells mediated by EP 2 receptors via PKA that was independent of Ca 2ϩ entry. Ca 2ϩ entry was important to maintain the basal sensitivity of the ACh response. IK but not BK channels were also shown to be involved. In addition, PGE 2 or forskolin enhanced ACh-induced whole-cell K Ca and CaCC currents and membrane hyperpolarization by enhancing Ca 2ϩ release from internal stores.
Role of Endoprostanoid Receptors and PKA. AChinduced ⌬I SC was sensitized by PGE 2 or forskolin pretreatment in mucous cells grown on CM inserts as shown by left shifts of concentration-response relationships for ACh-induced ⌬I SC (Fig. 1) , results similar to our previous findings . All four endoprostanoid receptors were present in SMGC but the sensitization effect of PGE 2 was dependent on the EP 2 receptor; The PGE 2 receptor antagonist AH6809 (EP 1 ϩ 2 ), but not SC19220 (EP 1 ), partially inhibited PGE 2 -induced ⌬I SC and reversed the PGE 2 -induced sensitization of the ACh response (Fig. 1) .
Furthermore PKA-specific blockers PKI 14-22, a pseudosubstrate for PKA (Glass et al., 1989) , and Rp-cAMP S , an antagonist of cAMP in binding to PKA (Schaap et al., 1993) , reduced PGE 2 -induced sensitization (Fig. 1) . PKA-catalytic subunit enhanced ACh-induced whole-cell currents (Fig. 7) . These data implicate the EP 2 receptor in sensitization because it is known to be coupled to the activation of PKA (Bos et al., 2004) . Besides activating PKA via EP 2 receptors, PGE 2 can also activate EP 4 receptors coupled to G s -protein capable of transactivating epidermal growth factor (EGF) receptors and receptor tyrosine kinases (Pai et al., 2002) . EGF receptor activation-prolonged ACh-induced Ca 2ϩ mobilization in SMGC has been shown to be dependent on tyrosine kinase activity and extracellular Ca 2ϩ (Iwase et al., 2002 (Shimura et al., 1994) . Removing external Ca 2ϩ (Fig. 2) or treatment with SKF96365 (Fig. 3) (Fig. 2) . Under normal [Ca 2ϩ ] o , 0.1 M PGE 2 caused 2.8- (Fig. 2 ) and 2.5-fold ( Fig. 1 ) and 1 M PGE 2 caused 2.7-fold (Fig. 3) increase in the apparent sensitivity to ACh. Likewise, after SKF96365 treatment, the -fold shifts in EC 50 s for the ACh response were 2.7-, 2.3-, 1.7-, and 2.1-fold in the presence of 0, 5, 25, and 50 M SKF96365, respectively (Fig. 3D) .
2-APB decreased ACh-induced maximal ⌬I SC and shortened the response. At 100 M, 2-APB greatly reduced both peak and sustained I SC induced by ACh in the presence of PGE 2 (Fig. 4, A and C) , effects that were not achieved by 0 mM [Ca 2ϩ ] o or SKF96365 treatments (Fig. 2, A and B, ⌬I SC and T 1/2 data). These data demonstrated that 2-APB, in addition to inhibiting ACh-induced Ca 2ϩ entry, inhibited ACh-induced/IP 3 receptor-mediated Ca 2ϩ release from internal stores, which was essential for the sensitization effect of PGE 2 /PKA on the ACh response.
Whole-cell current and Ca 2ϩ measurements in single mucous cells demonstrated that ACh induced K Ca and that CaCC currents were coincident with changes in [Ca 2ϩ ] i . Enhanced currents were a result of enhanced Ca 2ϩ mobilization (Figs. 6 and 7) . The existence of K Ca and CaCC in SMGC are consistent with previous reports (Griffin et al., 1996) . PGE 2 or forskolin enhanced ACh-induced peak currents and changes in peak [Ca 2ϩ ] i , indicating that ACh-induced Ca 2ϩ release from internal stores was enhanced. PGE 2 also prolonged ACh-induced ionic current [Ca 2ϩ ] i and membrane hyperpolarization (Figs. 7 and 8) , suggesting that prolonged Ca 2ϩ entry also occurred. Role of K ؉ Channels Involved. Direct sensitization of ion channels (for example K Ca ) to Ca 2ϩ by PKA is another possible mechanism responsible for PGE 2 -induced sensitization. A known effect of PKA is to enhance BK activities through phosphorylation (Tian et al., 2001) . Therefore, we examined the ability of forskolin to sensitize ACh-induced serosal K ϩ current. ChTX, the blocker for both IK and BK, abolished ACh-induced ⌬I SC (Fig. 5) . In contrast, IbTX, the specific blocker for BK, was ineffective in inhibiting ACh-induced I SC (Fig. 5) . Therefore, IK but not BK channels are involved in the ACh-induced I SC . Forskolin sensitized ACh-induced serosal K ϩ current also (Fig. 5) with a 2.4-fold increase in the apparent sensitivity of ACh. IbTX did not alter the maximal response or EC 50 for the AChinduced serosal K ϩ current. Clotrimazole, a blocker for IK (KCNN4), inhibited ACh-induced serosal K ϩ current. Clotrimazole also reversed the effect of forskolin in increasing the apparent sensitivity of the ACh response and reduced the maximal ACh-induced current (Fig. 5) . Forskolin-induced increases in K ϩ current were also blocked by clotrimazole but not by IbTX. Thus, IK instead of BK channels are the primary K ϩ channels activated during ACh-induced ⌬I SC . Direct effects of PKA in enhancing IK (KCNN4) activities are controversial (von Hahn et al., 2001) . PGE 2 or forskolin alone did not induce increases in [Ca 2ϩ ] i and whole-cell K ϩ or Cl Ϫ current (Fig. 7) , consistent with the report that cAMP-elevating agonists alone did not induce significant increases in [Ca 2ϩ ] i and whole-cell currents in mucous cells (Shimura et al., 1994) . PGE 2 induced membrane depolarization instead of hyperpolarization under current clamp (Fig. 8) , possibly because PGE 2 altered electrogenic ion transport or slightly enhanced Cl Ϫ or Na Ϫ channel activities. These data indicated that cAMP or PKA does not greatly activate or enhance K ϩ channel activities in single mucous cells. The PGE 2 responses in Ussing chamber and patch-clamp studies differ due to the fact that the former study used a mixed cell population and that patch clamp was performed using only mucus-containing cells. The serous cells in the primary culture expressed the cAMP-responsive ion channels CFTR and cAMP-activated K ϩ channels. However, blocking both channels did not change the sensitization effect of PGE 2 . PGE 2 -induced ⌬I SC responses were also significantly reduced by 0 mM [Ca 2ϩ ] o , SKF96365, and 2-APB treatments (Figs. 3, 4 , and 5), suggesting that normal Ca 2ϩ influx is also important in maintaining ion channel activities (such as KCa) that are associated with I SC response induced by intracellular cAMP elevation in serous cells.
Role of Ion Channels and [Ca 2؉ ] i Changes. Ca 2ϩ is important for mucin condensation and release (Verdugo, 1991) . CaCC are reportedly correlated with mucin production (Toda et al., 2002) in addition to mediating anion secretion. However, K ϩ current dominates the response to ACh (Iwase et al., 2002) , because mucous cells hyperpolarized in response to ACh close to the equilibrium potential for K ϩ (Ϫ80 mV; Fig. 8 ). Membrane hyperpolarization facilitates CaCC-dependent Cl Ϫ secretion and also facilitates Ca 2ϩ entry. Nonexcitable cells often lack voltage-dependent Ca 2ϩ channels, and Ca 2ϩ entry relies on a favorable electrochemical gradient (Penner and Fleig, 2004) . K ϩ channel-mediated membrane hyperpolarization increases and sustains a favorable driving force for Ca 2ϩ , enhancing Ca 2ϩ entry. Ca 2ϩ entry is responsible for the prolonged muscarinic actions and is more efficient than Ca 2ϩ -release from internal stores in causing glycoconjugate secretion (Ishihara et al., 1990 (Griffin et al., 1996) , increases in I SC , and glycoprotein secretion (Yang et al., 1991) . PKA is known to phosphorylate IP 3 receptors, enhancing ACh-induced Ca 2ϩ release from internal stores (Straub et al., 2004) . Furthermore, enhanced Ca 2ϩ entry may occur due to more efficient Ca 2ϩ store depletion. In summary, the elevated Ca 2ϩ levels induced at lower ACh concentrations after PGE 2 pretreatment resulted in an increase in apparent sensitivity to ACh. Such mechanisms may be involved in the enhanced airway fluid and mucus secretion during inflammation. Mediators released during airway inflammation, such as PGE 2 , play important roles as regulators of ACh-mediated airway fluid secretion and possibly mucin release. Ion channels such as IK and those responsible for Ca 2ϩ entry are potential targets for the treatment of mucus hypersecretion.
